Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, Israel

Israel implemented use of 7- and 13-valent pneumococcal vaccine in 2009 and 2010, respectively. We describe results of prospective, population-based, nationwide active surveillance of Streptococcus pneumoniae serotype 12F (Sp12F) invasive pneumococcal disease (IPD) dynamics in the 7 years after vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Rokney, Assaf, Ben-Shimol, Shalom, Korenman, Zinaida, Porat, Nurith, Gorodnitzky, Zeev, Givon-Lavi, Noga, Ron, Merav, Agmon, Vered, Dagan, Ron, Valinsky, Lea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823333/
https://www.ncbi.nlm.nih.gov/pubmed/29460732
http://dx.doi.org/10.3201/eid2403.170769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823333/
https://www.ncbi.nlm.nih.gov/pubmed/29460732
http://dx.doi.org/10.3201/eid2403.170769

Ejemplares similares